Searched for
MIRABEGRON
Zydus settles US Mirabegron patent dispute with Astellas for $120 millionZydus Lifesciences and its US subsidiary have settled patent litigation with Astellas Pharma over Astellas' Myrbetriq. Zydus will pay Astel...12 Feb, 2026, 09.00 AM IST- Lupin clears Mirabegron patent dispute with Astellas in $90 million deal, secures US sales continuityDrugmaker Lupin has settled a patent infringement dispute with Astellas Pharma over its Mirabegron product for $90 million. The agreement i...10 Feb, 2026, 08.44 AM IST
- Can domestic formulations shield Indian pharma from US pricing pressure in Q3?Indian drugmakers anticipate a mixed third quarter. Domestic sales and new specialty drugs will drive growth. US generics will see new prod...16 Jan, 2026, 06.04 AM IST
- Lupin shares gain 3%, up for second straight session. Here’s whyLupin shares saw an uptick after Jefferies raised its target price and reiterated a “Buy” rating post-strong Q2 results. The US business hi...10 Nov, 2025, 12.55 PM IST
- Buy, Sell or Hold: Nuvama raises target price on Cummins India; recommends buy on Lupin post Q2 resultsBrokerages maintained a bullish stance on Cummins India, Lupin, and Amara Raja Energy & Mobility, citing strong earnings, margin expansion,...10 Nov, 2025, 09.43 AM IST
- Stocks to buy today: Wipro gets downgraded post Q4 results; Lupin could see over 20% upsideBrokerages are showing caution on specific stocks due to factors impacting earnings visibility. Nuvama downgraded Wipro to "Hold," citing w...17 Apr, 2025, 10.56 AM IST
- Zydus Lifesciences Q1 results: Net profit jumps 31% to Rs 1420 croreThe earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 38.4% YoY to Rs 2084 crore. On QoQ, EBITDA increased 2...12 Aug, 2024, 06.38 AM IST
- Time to buy pharma? 3 stocks Forum Parekh is betting onZydus Life's US business is going to report a good set of numbers. Also, in India, wellness products are doing good, Overall Zydus Life wil...05 Jul, 2024, 08.11 AM IST
- Zydus Lifesciences launches generic drug for overactive bladder in US marketZydus is among the first suppliers to launch the generic version of Mirabegron extended-release tablets (USP 25 mg) in the US market. The c...22 Apr, 2024, 12.05 PM IST
- Just coming to our own in India; confident of growing our US business in next fiscal year: Lupin managementLupin's margin guidance remains around 19.5-20.5%. The company attributes its success to the pivot to complex products, cost-led initiative...09 Feb, 2024, 09.04 AM IST
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...04 Jan, 2024, 02.09 PM IST
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...10 May, 2023, 01.13 PM IST
- Zydus Lifesciences rises 4% on getting approval from USFDA for Mirabegron Tablets“Zydus was one of the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification for Mirabegron Extend...03 Oct, 2022, 12.26 PM IST
- Lupin rallies 4% after multiple approvals from USFDAIn a regulatory filing, the company said it has received approval from the USFDA for mirabegron extended-release tablets.30 Sep, 2022, 01.00 PM IST
- Stocks in the news: Here Moto, Indian Oil, Lupin, PNB and Adani Group stocksHero MotoCorp, the two-wheeler manufacturer, said it will invest $60 million in US-based Zero motorcycles to jointly develop electric motor...30 Sep, 2022, 07.22 AM IST
- Stocks in the news: Cox & Kings, Sadbhav Infra, Lupin, Tata Steel & Sun PharmaNMDC has terminated a Rs 1,400-cr contract with BHEL for building the raw material handling system.28 Jun, 2019, 08.54 AM IST
- Zydus Cadila gets tentative USFDA nod for overactive bladder treatment drugThe product will be manufactured at the group's manufacturing facility at SEZ in Ahmedabad.02 Apr, 2019, 01.07 PM IST
Load More
